The Analyst Landscape: 7 Takes On AnaptysBio
The Analyst Landscape: 7 Takes On AnaptysBio
分析师格局：对AnaptysBio的7种看法
In the preceding three months, 7 analysts have released ratings for AnaptysBio (NASDAQ:ANAB), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，有7位分析师发布了AnaptysBio（纳斯达克股票代码：ANAB）的评级，提出了从看涨到看跌的各种观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级，简要介绍了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for AnaptysBio, presenting an average target of $50.0, a high estimate of $80.00, and a low estimate of $28.00. Surpassing the previous average price target of $30.00, the current average has increased by 66.67%.
在对12个月目标股价的评估中，分析师公布了对AnaptysBio的见解，将平均目标价定为50.0美元，最高估计为80.00美元，低估值为28.00美元。超过了之前的平均目标股价30.00美元，目前的平均价格上涨了66.67％。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级：一项详尽的研究
A comprehensive examination of how financial experts...
对金融专家如何...
登录免费看全文
登录/注册